Stay updated on Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T18:27:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision history on the page updated: added v3.3.1 and removed v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:50:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Removal of the banner about possible data delays and operating status due to funding lapses; this is a general site-wide notice and does not alter the study-specific information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:11:23.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    No significant changes were detected between the two screenshots of the study page. The core study details—title, conditions, interventions, eligibility criteria, and outcome measures—remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:24:28.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updated page with a government-funding status notice and an OS/operating details section, plus a version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-05T10:21:07.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:49.000Z thumbnail image

Stay in the know with updates to Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib and Nivolumab in Metastatic Kidney Cancer Clinical Trial page.